190 related articles for article (PubMed ID: 29028290)
1. Plasminogen activator inhibitor-1 regulates the vascular expression of vitronectin.
Luo M; Ji Y; Luo Y; Li R; Fay WP; Wu J
J Thromb Haemost; 2017 Dec; 15(12):2451-2460. PubMed ID: 29028290
[TBL] [Abstract][Full Text] [Related]
2. Multifaceted role of plasminogen activator inhibitor-1 in regulating early remodeling of vein bypass grafts.
Ji Y; Strawn TL; Grunz EA; Stevenson MJ; Lohman AW; Lawrence DA; Fay WP
Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1781-7. PubMed ID: 21571686
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation.
Ji Y; Weng Z; Fish P; Goyal N; Luo M; Myears SP; Strawn TL; Chandrasekar B; Wu J; Fay WP
Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2167-2175. PubMed ID: 27659097
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor-1 and vitronectin expression level and stoichiometry regulate vascular smooth muscle cell migration through physiological collagen matrices.
Garg N; Goyal N; Strawn TL; Wu J; Mann KM; Lawrence DA; Fay WP
J Thromb Haemost; 2010 Aug; 8(8):1847-54. PubMed ID: 20492459
[TBL] [Abstract][Full Text] [Related]
5. Recombinant plasminogen activator inhibitor-1 inhibits intimal hyperplasia.
Wu J; Peng L; McMahon GA; Lawrence DA; Fay WP
Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1565-70. PubMed ID: 19574558
[TBL] [Abstract][Full Text] [Related]
6. Endogenous vitronectin and plasminogen activator inhibitor-1 promote neointima formation in murine carotid arteries.
Peng L; Bhatia N; Parker AC; Zhu Y; Fay WP
Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):934-9. PubMed ID: 12067901
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor 1 and vitronectin protect against stenosis in a murine carotid artery ligation model.
de Waard V; Arkenbout EK; Carmeliet P; Lindner V; Pannekoek H
Arterioscler Thromb Vasc Biol; 2002 Dec; 22(12):1978-83. PubMed ID: 12482822
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice.
Eitzman DT; Westrick RJ; Nabel EG; Ginsburg D
Blood; 2000 Jan; 95(2):577-80. PubMed ID: 10627465
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice.
Konstantinides S; Schäfer K; Thinnes T; Loskutoff DJ
Circulation; 2001 Jan; 103(4):576-83. PubMed ID: 11157725
[TBL] [Abstract][Full Text] [Related]
10. Effect of pharmacologic plasminogen activator inhibitor-1 inhibition on cell motility and tumor angiogenesis.
Leik CE; Su EJ; Nambi P; Crandall DL; Lawrence DA
J Thromb Haemost; 2006 Dec; 4(12):2710-5. PubMed ID: 17010152
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator-1 overexpression decreases experimental postthrombotic vein wall fibrosis by a non-vitronectin-dependent mechanism.
Obi AT; Diaz JA; Ballard-Lipka NL; Roelofs KJ; Farris DM; Lawrence DA; Wakefield TW; Henke PK
J Thromb Haemost; 2014 Aug; 12(8):1353-63. PubMed ID: 24943740
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor-1 inhibits angiogenic signaling by uncoupling vascular endothelial growth factor receptor-2-αVβ3 integrin cross talk.
Wu J; Strawn TL; Luo M; Wang L; Li R; Ren M; Xia J; Zhang Z; Ma W; Luo T; Lawrence DA; Fay WP
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):111-20. PubMed ID: 25378411
[TBL] [Abstract][Full Text] [Related]
13. Wound-induced migration of MDA-MB-435 and SKOV-3 cancer cells is regulated by plasminogen activator inhibitor-1.
Whitley BR; Church FC
Int J Oncol; 2005 Sep; 27(3):749-57. PubMed ID: 16077925
[TBL] [Abstract][Full Text] [Related]
14. Vitronectin expression and interaction with receptors in smooth muscle cells from human atheromatous plaque.
Dufourcq P; Louis H; Moreau C; Daret D; Boisseau MR; Lamazière JM; Bonnet J
Arterioscler Thromb Vasc Biol; 1998 Feb; 18(2):168-76. PubMed ID: 9484980
[TBL] [Abstract][Full Text] [Related]
15. Role of cAMP-phosphodiesterase 1C signaling in regulating growth factor receptor stability, vascular smooth muscle cell growth, migration, and neointimal hyperplasia.
Cai Y; Nagel DJ; Zhou Q; Cygnar KD; Zhao H; Li F; Pi X; Knight PA; Yan C
Circ Res; 2015 Mar; 116(7):1120-32. PubMed ID: 25608528
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Smooth Muscle β-Catenin Hinders Neointima Formation After Vascular Injury.
Riascos-Bernal DF; Chinnasamy P; Gross JN; Almonte V; Egaña-Gorroño L; Parikh D; Jayakumar S; Guo L; Sibinga NES
Arterioscler Thromb Vasc Biol; 2017 May; 37(5):879-888. PubMed ID: 28302627
[TBL] [Abstract][Full Text] [Related]
17. The vitronectin-binding function of PAI-1 exacerbates lung fibrosis in mice.
Courey AJ; Horowitz JC; Kim KK; Koh TJ; Novak ML; Subbotina N; Warnock M; Xue B; Cunningham AK; Lin Y; Goldklang MP; Simon RH; Lawrence DA; Sisson TH
Blood; 2011 Aug; 118(8):2313-21. PubMed ID: 21734232
[TBL] [Abstract][Full Text] [Related]
18. The P2Y2 receptor mediates uptake of matrix-retained and aggregated low density lipoprotein in primary vascular smooth muscle cells.
Dissmore T; Seye CI; Medeiros DM; Weisman GA; Bradford B; Mamedova L
Atherosclerosis; 2016 Sep; 252():128-135. PubMed ID: 27522265
[TBL] [Abstract][Full Text] [Related]
19. Leptin promotes neointima formation and smooth muscle cell proliferation via NADPH oxidase activation and signalling in caveolin-rich microdomains.
Schroeter MR; Leifheit-Nestler M; Hubert A; Schumann B; Glückermann R; Eschholz N; Krüger N; Lutz S; Hasenfuss G; Konstantinides S; Schäfer K
Cardiovasc Res; 2013 Aug; 99(3):555-65. PubMed ID: 23723060
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor-1 and vitronectin promote the cellular clearance of thrombin by low density lipoprotein receptor-related proteins 1 and 2.
Stefansson S; Lawrence DA; Argraves WS
J Biol Chem; 1996 Apr; 271(14):8215-20. PubMed ID: 8626514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
